Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Orthocell Ltd ( (AU:OCC) ) has issued an update.
Orthocell Ltd has announced the issuance of 1,563,271 new ordinary fully paid securities, which will be quoted on the Australian Securities Exchange (ASX) under the code OCC. This move is part of the company’s strategy to enhance its capital structure, potentially improving its market position and providing additional resources for its ongoing research and development efforts.
The most recent analyst rating on (AU:OCC) stock is a Hold with a A$1.50 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine and tissue engineering. The company is known for its innovative products aimed at repairing and regenerating damaged tissues, with a market focus on improving patient outcomes in orthopedic and dental applications.
Average Trading Volume: 544,192
Technical Sentiment Signal: Buy
Current Market Cap: A$306.6M
Find detailed analytics on OCC stock on TipRanks’ Stock Analysis page.